Could this be the solution to chronic pain—and the opioid crisis?
Early research suggests that monoclonal antibodies—used to protect the vulnerable from COVID-19—may provide non-addictive, long-lasting pain relief from a variety of conditions.
This content is Subscriber-Exclusive
You must have a National Geographic subscription to explore this article.
